Article Text
Statistics from Altmetric.com
Background
The European Patients’ Academy (EUPATI) is a pan-European Innovative Medicines Initiative project of 33 organisations, led by the European Patients’ Forum with partners from patient organisations (the European Genetic Alliance, the European AIDS Treatment Group and EURORDIS), universities and not-for-profit organisations, along with a number of European pharmaceutical companies. EUPATI aims to help patients to be more educated and involved in the research and development process of new medicines, by offering reliable, objective, comprehensive lay-friendly information and training on the research and development process of medicines. EUPATI increases the capacity of patients to be effective advocates with meaningful involvement in areas like drug discovery and non-clinical testing, planning and conduct of clinical trials, regulatory affairs, assessment of safety of medicines, benefit-risk assessment, as well as principles of health technology assessment. The first EUPATI Patient Expert …
Footnotes
Twitter Follow Alison Twycross at @alitwy, Gary Mitchell at @GaryMitchellRN and Nóirín O'Neill at @Noirin0Neill
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.